David Long Named CFO of Cynosure

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

David Long has been named Chief Financial Officer of Cynosure effective immediately. With more than 25 years of global finance experience and a proven track record of success, the Cynosure reports David Long will help accelerate the company’s business transformation and growth plans under the new leadership of Chief Executive Officer and former Hershey and Unilever executive, Todd Tillemans.

Mr. Tillemans said, “This is an exciting time as we look to position Cynosure for long-term sustainable growth and we’re thrilled to have David join the team. He is a highly respected finance leader who will be invaluable as we prioritize investments in new innovation to drive our customers’ businesses, and ultimately provide patients around the globe with best-in-class technology and service.”

Until recently, Long served as CFO at Corindus Vascular Robotics, Inc. where he led numerous commercial and operational improvements, successfully brought the company public and, ultimately, navigated its strategic sale to Siemens. Prior to his time at Corindus, Long spent nearly a decade at Thermo Fisher Scientific, where he held the position of Vice President of Finance of the Laboratory Equipment Division. Long also served as an adjunct professor in the Department of Accountancy at Bentley University.

“I’m excited to join such a strong team of leaders,” Long said. “I’m eager to get to work and make an impact alongside the leadership team to ensure we remain positioned for continued success and deliver the market-leading technology clinicians and consumers rely on from Cynosure.”

Long holds a Master of Public Administration from the University of Pennsylvania and a Bachelor of Science in Finance from the University of Massachusetts.

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.